BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:02 PM
Jun 06, 2007
 |  BC Extra  |  Clinical News

Roxro reports Phase III pain data

Roxro (Menlo Park, Calif.) said patients receiving 30 mg of ROX-888 reported a 31% greater improvement in pain relief over...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >